Acquiring Company
Medios AG
Acquired Company
Caesar & Loretz GmbH
GermanyNorth Rhine WestphaliaManufacturingBiotechnologyPharmaceuticalManufacturingBiotechnologyPharmaceuticalDescription
Medios AG has signed an agreement to acquire a 74% stake in Caesar & Loretz GmbH (Caelo) as part of its growth strategy. The acquisition will expand Medios' offerings in the European pharmaceutical market, particularly in Germany. This transaction is subject to closing conditions, including antitrust clearance. Caelo's expertise in active pharmaceutical ingredients positions Medios for enhanced market presence.
M&A Insights
Based on deal dataFrequently asked
Who acquired Caesar & Loretz GmbH?
Caesar & Loretz GmbH was acquired by Medios AG, based in Germany. The deal was reported on August 12, 2026. Medios AG is a leading provider of specialty pharmaceuticals in Europe. The company focuses on optimizing operational efficiency, profitability, and cash conversion. Medios AG is privately held and operates in Manufacturing.
When did Medios AG acquire Caesar & Loretz GmbH?
Medios AG's acquisition of Caesar & Loretz GmbH was reported on August 12, 2026. Medios AG has signed an agreement to acquire a 74% stake in Caesar & Loretz GmbH (Caelo) as part of its growth strategy. The acquisition will expand Medios' offerings in the European pharmaceutical market, particularly in Germany. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Caesar & Loretz GmbH do?
Caesar & Loretz GmbH, known as Caelo, is a supplier of active pharmaceutical ingredients, excipients, and raw materials. It is privately held, operating in Manufacturing, and is based in North Rhine Westphalia.